Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation

Published:2018-04 Issue:4 Volume:24 Page:751-757
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Shimoni Avichai^ORCID,Labopin Myriam,Savani Bipin,Hamladji Rose-Marie,Beelen Dietrich,Mufti Ghulam,Socié Gerard,Delage Jeremy,Blaise Didier,Chevallier Patrice,Forcade Edouard,Deconinck Eric,Mohty Mohamad,Nagler Arnon

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need;Shimoni;Best Pract Res Clin Haematol,2011

2. Defining the intensity of conditioning regimens: working definitions;Bacigalupo;Biol Blood Marrow Transplant,2009

3. Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes;Scott;J Clin Oncol,2017

4. Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike;Danylesko;Bone Marrow Transplant,2011

5. Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics;ten Brink;Drug Discov Today,2014

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center;Cancer Medicine;2024-05

2. Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison;Bone Marrow Transplantation;2024-02-21

3. Conditioning;The EBMT Handbook;2024

4. Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT;HemaSphere;2023-09-20

5. Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP);Bone Marrow Transplantation;2023-07-07